We are live on
!
Find out more
KS
Karpas Strategies Portfolio holdings
AUM
$319M
1-Year Est. Return
14.42%
This Fund
S&P 500
This Quarter
Est. Return
+11.61%
1 Year Est. Return
+14.42%
3 Year Est. Return
+16.12%
5 Year Est. Return
+59.2%
10 Year Est. Return
+120.15%
AUM
$302M
AUM Growth
+$30.1M
(+11%)
Cap. Flow
+$1.55M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
46.2%
Holding
121
New
7
Increased
39
Reduced
43
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US High Profitability ETF
DUHP
|
+$1.37M |
| 2 |
Brookfield
BN
|
+$1.21M |
| 3 |
Apple
AAPL
|
+$1.2M |
| 4 |
Brookfield Infrastructure
BIPC
|
+$1.08M |
| 5 |
Eli Lilly
LLY
|
+$337K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Latin America Class C
LILAK
|
+$517K |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$447K |
| 3 |
Thermo Fisher Scientific
TMO
|
+$367K |
| 4 |
Warner Bros
WBD
|
+$338K |
| 5 |
Citigroup
C
|
+$312K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 36.41% |
| 2 | Healthcare | 15.25% |
| 3 | Energy | 12.04% |
| 4 | Technology | 8.16% |
| 5 | Utilities | 6.99% |
Similar funds
RMC
GH
GFWEX
CCMLC
CU
LWMG
THWM
VFPI
Karpas Strategies's Q4 2023 Portfolio in Review
As of Q4 2023, Karpas Strategies held 121 positions worth $302M, up 11% from $272M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Karpas Strategies's Q4 2023 filing shows 7 new, 39 increased, 43 reduced and 4 closed positions. Its largest new stake was Dimensional US High Profitability ETF: 51,283 shares worth $1.47M. The largest sale was Liberty Latin America Class C, an estimated $517K.
By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Energy.
- Karpas Strategies's largest Q4 2023 buy was Dimensional US High Profitability ETF: 51,283 shares worth $1.47M.
- Karpas Strategies added most to Brookfield in Q4 2023, an estimated $1.21M increase.
- Karpas Strategies's biggest Q4 2023 reduction was Liberty Latin America Class C, cutting an estimated $517K.
- Karpas Strategies fully exited Thermo Fisher Scientific in Q4 2023, selling an estimated $367K.
- Karpas Strategies's ten largest holdings make up 46% of its $302M portfolio in Q4 2023.
- Karpas Strategies opened 7 new positions and closed 4 in Q4 2023.
- Karpas Strategies's portfolio value rose 11% quarter-over-quarter to $302M.
Based on Karpas Strategies's 13F filing for Q4 2023, filed 7 Feb 2024.